|
|
 News Articles
Opportunities and Resources
Advice Corner
New Initiatives
|
News Articles
|
 |
Renewals Are New for SBIR
and STTR Phase II Grantees
If you're a Phase II SBIR or STTR grantee, take heed! NIAID will start
accepting renewal applications for Phase II SBIR and STTR
awards beginning with the first 2005 receipt dates. The support will
let you continue assessing and improving drugs or devices or conduct
preclinical studies. The research must require clinical evaluation, regulatory
(e.g., FDA) approval, or continuing refinements to durable medical equipment
designs.
If this sounds interesting, we strongly encourage you to contact Dr.
Gregory Milman at gmilman@niaid.nih.gov before submitting a renewal application.
NIAID will consider applications in its Small
Business High Priority Areas of Interest as well as in:
- Therapeutic drugs or antibodies to treat HIV infections.
- Therapeutic drugs or antibodies for HIV-related opportunistic infections.
- Anti-inflammatory therapeutics.
- Transgenic transplantation strategies.
- New or improved vaccines, antiviral agents, or antimicrobial agents for
infectious diseases.
You can apply for up to three years of support and up to $1 million
a year for total costs, provided you justify the time and amount. NIAID
will make funding decisions based on your priority score and funds available
in the Institute's budget. For details, see the PHS
2005-2 Omnibus Solicitation, which will be released around January
14, 2005. Call the program contacts listed in Small
Business High Priority Areas of Interest for science-related questions. |
 |
NIAID Seeks Applicants to
Lead Revamped HIV/AIDS Clinical Trials Networks
As part of NIAID's drive to restructure its HIV/AIDS clinical trials
resources, the Institute seeks new leadership to oversee its HIV/AIDS
clinical research networks, which will research domestic and international
treatments, preventions, and vaccines.
The RFA announcement for the leadership of the HIV/AIDS network in the November
19 NIH Guide lists six focal research areas: developing HIV
vaccines; translating research insights into therapeutic products; optimizing clinical management, including co-morbidities;
developing microbicides; preventing mother-to-child HIV transmission;
and developing other methods of HIV prevention.
Letters of intent are due from applicants on April 11, 2005; applications
are due on May 11, 2005. To inform the community about the new initiative,
NIAID held a pre-application meeting with potential applicants on December
13. You can view a video of the meeting and other materials, including
links to the RFA, at DAIDS
Clinical Trials Network FY 2006. Find news releases and fact sheets
on the NIAID home page.
A second RFA, to be released in early 2005, will solicit applications
for the clinical trials units that will conduct the Research Planned
by the networks. Funding for the two RFAs is expected to be up to $300 million
for the first year and to continue for up to seven years.
The new structure should increase efficiency, accountability, and integration
and enhance the network's research capacity. It will also enable DAIDS
to more effectively respond to global research needs, including those
of populations increasingly affected by HIV/AIDS and underrepresented
in clinical research. |
 |
Progress and Work Arounds
to Square With the New 398
As promised, we're letting you know that we made changes throughout
the Funding News site to
reflect the latest PHS 398. But until NIH posts the instructions in
HTML, we aren't linking to page-specific instructions; we're linking
to the main page of the 09/2004
PHS 398 instead.
As soon as the HTML instructions are online -- which should happen
in the next few weeks -- we will change the code throughout the Funding
site to link directly to the relevant instruction sections. For more
information, see our Note
Regarding Links to PHS 398 Instructions and the November
2, 2004, Guide notice. |
 |
Twist for Small Grant Applications
-- PAs Only, Please
If applying for a Small
Research Grant (R03) or Exploratory/Developmental
Grant Phase I (R21) has crossed your mind, there's one small
catch -- you can apply for these awards only in response to a program
announcement.
NIH will be looking for your citation of the PA number and title on
line 2 of the PHS 398 face page. If you leave it out, you may get a call
asking you to identify the PA. CSR will also check that the application
conforms to the unique features of the PA, such as budget limits or
eligibility requirements, and that the science fits the research of
at least one of the sponsoring ICs.
On NIH Funding Opportunities Relevant to NIAID, you can find the general NIH-wide NIH
Small Research Grant Program and NIH
Exploratory/Developmental Research Grant Award along with
PAs using these mechanisms that are directed toward more institute-specific
areas of science. |
 |
Remembering
John La Montagne
NIAID created a new Web site to honor John R. La Montagne, Ph.D.,
our former deputy director who died suddenly on November 2. Please
visit the site In
Memory of John R. La Montagne, Ph.D.
|
 |
Cliff Lane Is Acting Deputy
Director
Dr. Cliff Lane has begun acting as NIAID deputy director, filling
the vacancy created by the death of Dr. La Montagne. He will also continue
as the Institute's clinical director and director of the Office of Clinical
Research.
NIAID Director Dr. Anthony S. Fauci welcomed him to the new role, "Dr.
Lane has done an extraordinary job and is widely respected within the
NIH and extramural community. I am very pleased that he has agreed to
take on this additional responsibility." |
Opportunities and Resources
|
 |
Attention
Applicants: Check Our Qs and As
If you're applying for a grant, be sure to check our questions and answers
designed especially for applicants by NIAID's own scientific review officers.
Find them on the NIH Funding Opportunities Relevant to NIAID list -- look for the Q&A graphic
highlighting each Q&A link.
Each document has general questions at the bottom and questions specific
to the initiative at the top. You can also find the generic questions
and answers for RFAs and Multiproject Applications -- with more topics
to come -- on NIAID
Funding Questions and Answers under the RFAs, RFPs, and PAs header.
As soon as our SROs or program officers receive questions from applicants,
we'll add the new questions above existing ones and a new date header
to indicate what's changed. Periodically, we'll also add new questions
to the general questions, as we did on November 17; you'll be able to
tell by the date in the header.
For contracts, we post questions and answers prepared by our contracting
staff as a separate amendment in PDF format on the same NIH Funding Opportunities Relevant to NIAID list. |
 |
Site Qs and As, Flow Charts Make Navigating
a Breeze
We may not have electronic GPS, but our new navigational tools can help
you make your way to that crucial tidbit of information on the NIAID
Funding site. If the left navigation bar leads you down a dark alley, try
looking for your question on NIAID
Funding Questions and Answers. This steadily expanding site already
contains dozens of Q&As that take you to content throughout the site.
For example, let's say you just received your summary statement and
see a mysterious code 44 you need to investigate. In the initial peer
review section of the Funding Questions and Answers, choose After
Initial Peer Review. Then you can either scroll down till you see
information about codes, or use your browser's find function (control
F in Internet Explorer and Mozilla) to search for "code." The
answers tell you more about the codes peer reviewers add to reflect their
concerns about research animals, human subjects, or biohazards. They
also point you to SOPs
as well as relevant tutorial pages from All
About Grants.
Our process flow charts are a new navigational tool for our extramural Standard
Operating Procedures. Even if you're not sure of the lingo, you
can use them to locate the right SOP if you know roughly where in
the grand scheme of things your question applies.
For example, suppose you want to learn more about how to handle grant
funds. See the No-Cost
Extension SOP, Carryover
Requests SOP, and more. You can still look up SOPs by Topic, too. We plan to build flow charts for R&D contracts
next.
As always, you can browse from the Funding
home page, the Site
Map, and our comprehensive alphabetical Find
It! list of links and resources. To stay on top of the latest developments,
be sure to regularly check Latest
Site Updates, Top
Policy Changes, and Special
Announcements. The latter gives you recent policy and funding announcements
that are not on our NIH Funding Opportunities Relevant to NIAID list. |
Advice Corner
|
 |
Reader
Question on the Difference Between Supplements and Compensation
Susan Rich, Ph.D., director, Office of Postdoctoral Education, Emory
University School of Medicine, wrote:
"In reference to the Reader
Question on Supplementing NRSA Stipends, the terms 'supplement'
and 'compensate' refer to different mechanisms to provide funding
to an NRSA fellow or trainee. However, many administrators and faculty
use the term 'supplement' in a nonspecific sense to refer to compensation.
Could you highlight the usages and their implications in common terms?"
The newsletter question Dr. Rich refers to was: "Since we are in
New York City, the NIH training grant stipends are often not enough money
for my graduate students and postdoctoral fellows to live on. Am I allowed
to supplement their salaries with other NIH grants such as
my R01?"
And our answer, "Sorry, it's against regulations to supplement
an NRSA stipend with funds from an NIH grant," warrants further
clarification. You can pay compensation (salary or tuition remission)
to a fellow or trainee from grant monies for services such as teaching
or laboratory assistance. Compensation should be for limited, part-time
employment apart from the normal training activities and not detract
from or prolong the training.
Compensation is not an NIH supplement, which is a funding instrument
to add money to an existing NIH research grant. Supplements
come in three flavors: competing supplements, administrative supplements,
and research supplements. Trainees and fellows are compensated with stipends,
money allocated in training
grants and fellowships to
pay for living expenses, at levels set by NIH each year.
Here are our glossary definitions:
Compensation -- Salary or tuition remission paid to a fellow or trainee
from grant monies for teaching or lab work; must be limited, part-time,
and separate from the training.
Competing supplements -- Funds added to a grant for a significant expansion
of an existing project's scope or to meet needs of a research protocol
costing more than $50,000. Applicants must apply to NIH using the PHS
398 and undergo peer review.
Administrative supplements -- Monies added to a grant without peer
review to pay for items within the scope of an award,
but unforeseen when a grant
application was submitted.
Research supplements -- Monies that add funds to an existing grant to
support and recruit minorities,
people with disabilities,
and people returning
to work from family responsibilities. Find more information on our training
Web site -- go to Research supplements to promote diversity, and Research
supplements for reentry into a scientific career.
Stipend -- Student financial support provided on training
grants and fellowships for
living expenses. For details, see NRSA
Stipend Levels -- FY 2004 until we receive the new FY 2005 levels. |
 |
Reader Question on NIH's
Public Access Policy and Data Sharing
Daniella Livnat, Health Specialist, Therapeutics Research Program, Division
of AIDS, asks:
"Your November 8, 2004, article says NIH's new public access
policy will help investigators meet the publications requirement for
progress reports. Does it also fulfill the data sharing requirement?"
No. The NIH Public Access site posts your manuscript six months after
publication. The data sharing plan requires sharing the final data set
(identifiers removed) through your institution, no later than the acceptance
date for publication of the main findings. For more information, see
the Data
Sharing FAQ and the Final NIH Statement on Sharing Research Data
in the February
26, 2003, NIH Guide notice. |
 New
Initiatives
|
 |
|
Subscribe to Alerts
